Elon Musk’s Neuralink has initiated the recruitment of subjects for its first human clinical trial, aiming to explore the potential of its creepy brain-computer interface technology that has produced nasty results for unfortunate test monkeys in recent years.
The Verge reports that after securing FDA approval a few months ago, Elon Musk’s Neuralink is stepping into uncharted territories with its six-year initial trial, officially titled “the PRIME Study.” This innovative research is designed to scrutinize Neuralink’s cutting-edge technology, which it believes can empower those suffering from paralysis due to spinal cord injuries or ALS, enabling them to manipulate devices through the interface. Elon Musk, billionaire and chief executive officer of Tesla, at the Viva Tech fair in Paris, France, on Friday, June 16, 2023. Musk predicted his Neuralink Corp. would carry out its first brain implant later this year. Photographer: Nathan Laine/Bloomberg The PRIME […]
Read the Whole Article From the Source: www.breitbart.com
It’s becoming increasingly clear that fiat currencies across the globe, including the U.S. Dollar, are under attack. Paper money is losing its value, translating into insane inflation and less value in our life’s savings.
Genesis Gold Group believes physical precious metals are an amazing option for those seeking to move their wealth or retirement to higher ground. Whether Central Bank Digital Currencies replace current fiat currencies or not, precious metals are poised to retain or even increase in value. This is why central banks and mega-asset managers like BlackRock are moving much of their holdings to precious metals.
As a Christian company, Genesis Gold Group has maintained a perfect 5 out of 5 rating with the Better Business Bureau. Their faith-driven values allow them to help Americans protect their life’s savings without the gimmicks used by most precious metals companies. Reach out to them today to see how they can streamline the rollover or transfer of your current and previous retirement accounts.